JavaScript is required

Latest Blog Posts

Please help, I will notify the Bank. I provided everyone with corporates number. My loans were paid off long ago and in a few years I retire. Our bosses suggestion was that we add on another patient to the day. I dream of the day that I could afford to work in a private practice, or even take the financial risk to open my own cash pay practice..

Thank you! Please check your inbox for an email from me.

This will have a broad impact, from providing robust clinical evidence to developing innovative new products and personalized treatment paradigms. Inna Glozman — Rising Star Senior Director, Commercial Analytics, Eisai Advances in health technology will continue to enable improved patient care and create new avenues for scientific innovation.

Petra Jantzer — Luminary Managing Director, Accenture Digitization of healthcare and the power of big data are two big trends. The convergence of biology, data science, and digital technologies will drive medicines and health progress in this century as dramatically as the extraordinary achievements in physics, electronics, and engineering that revolutionized the last one.

Andrea Kretzmann — Luminary Strategy, Fingerpaint Marketing Genomics is finally hitting the main stage for consumers at the same time as broader scale adoption of wearables and integration with virtual assistants such as Alexa.

People have unprecedented, and individual, information at their fingertips and are in more control of charting their health futures with and without their physicians. Companies are using these digital resources in innovative ways to improve outcomes across the health sector. As lawyers, we have to embrace the use of digital technologies, partner with our digital teams early in the design phase, and provide guidance on the regulatory and legal requirements associated with these digital technologies.

The HCPs of the future will depend on data streams and analysis as much they depend on the physical exam to diagnose and treat patients. Patients will be well-informed and prefer healthcare providers who use the best technological systems to treat their illnesses and maintain wellness. Wearables will provide continuous patient assessment and personalized medicine will become the norm. The pharma industry must partner with the healthcare community to meet the needs and requirements of patients of the future.

It is allowing patients to increase awareness and ownership of their health and well-being and healthcare professionals to diagnose and treat on a broader scale. It is also playing a key role in improving health outcomes through value-based approaches. Technology is at the center of the healthcare transformation, serving as a key differentiator and defining the customer experience.

The advancement of digital therapeutics will provide an opportunity for biology and technology to further complement each other, while advances in social media platforms will allow advocacy groups to better understand and share patient experiences and burden of disease. In many ways this will shift the paradigm to more patient responsibility and self-advocacy, while providing new ways to engage with our healthcare providers.

There are many examples of this, from the simple to the complex. Wearable devices, which help us monitor our own exercise, calorie intake, sleep patterns, etc. I work with an autoinjector that will remind patients to take their medication and track compliance, as well as provide a visual calendar and wellness tracker.

Patients can also choose to send data to a healthcare provider. Various health plans and systems are experimenting with different forms of telemedicine. This is a way to gain virtual access to physicians and enhance the timeliness and quality of healthcare delivery to patients.

This will only accelerate as more people have access to tools such as smartphones and as technology continues to improve across the globe.

Health services are already being delivered or enhanced through the Internet and related technologies. For example, instead of going to a bricks-and-mortar urgent care center for treatment of their flu symptoms, some people are opting to connect with doctors using telemedicine services.

Another example is the use of activity trackers to monitor physical activity, which have expanded to track sleep, respiration, and other vital activities in real time. While data are going to exponentially increase, so will the challenge to identify credible and evidence-based information that can be used to help solve key societal issues from the impact of disease on communities to helping improve the quality of life of an individual.

How do organizations use these disruptive technologies to achieve a mission that is of societal benefit? These are the questions for our time. Specifically, the proliferation of diagnostic technology and health information in the management of chronic diseases will empower patients to be more aware, informed, and in control of their own health. Jodi Virkus — Rising Star Oncology Marketing Indication Lead, Novartis Pharmaceuticals The speed of change in technology, science, and medicine continue to outpace the ability of many of our customers to keep up.

This creates the need for ever-increasing simplicity and solutions that make it easy for the healthcare system and physicians.

In times when efficacy and safety are key, these are now expected, and additional solutions have to be provided to compete. Not only is digital technology improving patient outcomes in eye care — it is rapidly changing how large companies such as Alcon are working with suppliers. Emerging technologies are breaking down silos between big companies and tiny start-ups to improve the supply chain in ways that were not possible even a few years ago.

Stephanie Bostaph Martin — Rising Star VP, Ketchum Amazon is paving the way for companies — not traditionally known in healthcare — to disrupt the marketplace, bringing greater scrutiny to pricing, transparency, and access. The real question is whether this can have a widespread impact on the total cost of healthcare in the United States from the cost of prescriptions to procedures. Tanesha Duncan — Rising Star Executive Director, Technical Commercialization, Celgene If you look back 10 to 15 years, you can point to several industries that have been completely disrupted by the introduction of technological innovation that toppled major powerhouses and created opportunities for new entrants to exploit.

Examples of companies that were formed out of these major shifts in industry dynamics include Amazon for retail, Netflix for entertainment, Spotify and Pandora for the music industry, and Blue Apron and HelloFresh for the grocery industry, to name just a few.

Over the last few years, the healthcare industry has seen several technology companies entering the space during a time when the industry is ripe for disruption. The proliferation and accessibility of data and the technological advances that allow us to mine this data quickly and accurately will enable innovation across science, clinical development, access, reimbursement, and medical practice in the near future.

Harnessing analytics in healthcare will be one of the major enablers that builds a bridge to personalized healthcare and innovative patient care solutions.

Jessica Hill — Rising Star Senior Account Manager, Bulletin Healthcare The entrance of Amazon into the pharmacy space could upend the industry, depending on the exact direction the company decides to go in.

Consumers have increasingly more power in the healthcare marketplace and one can only imagine how the pharmacy model will change if consumers become accustomed to the convenience, responsive customer service, and fast shipping offered via Amazon in their health purchases.

Additionally, consumers may come to expect the same level of service from their healthcare providers, insurers, and pharmaceutical companies. In a recent KPMG survey, two-thirds of CEOs said they believed that the next three years will be more critical for their operations than the previous 50 and that they were worried about their business models being disrupted. New entrants, consumer-centricity, and rapid technological advancement will reshape how the life-sciences industry operates.

We are at a tipping point in the industry that will have far-reaching implications for patients, healthcare providers, and the cultural dynamics in the sector. Platform companies such as Amazon and Apple are quietly positioning themselves across the healthcare value chain, for example diagnostics, clinical research, and information capture, and distribution. The future holds great promise: Change will also threaten organizations that fail to pivot from traditional operating models.

Anticipating, transforming, and reinventing will be essential to navigating this uncertain and dynamic environment. Sonia Luaces — Rising Star Partner, PwC New sector entrants and emerging technologies continue to spur innovative partnerships through horizontal and vertical integration efforts, driving the sector to reevaluate existing business models, re-balance investments, and maximize cost structures. The use of real-world data is unlocking medical mysteries, improving patient care, and informing new areas of research.

Healthcare technology companies such as Illumina are leveraging genomic data to decode rare diseases and identify new areas of health research. Artificial intelligence and real-world data are enabling better patient care and faster treatment decisions. Today, oncologists can leverage platforms such as CancerLinQ to track real-world data, making better and faster treatment decisions possible.

The next frontier will take place when we find new ways to break down data silos, enabling easier sharing and collaboration in the name of better patient care.

This is going to require overhauling the delivery model, which will be dependent on new technology to enable connectivity. Cecilia Soriano — Luminary VP, General Manager, Diabetes Care, BD While there are multiple trends with significant impact to our industry, the one trend that is most material to the business I am currently in is the consolidation between retailers and payers, for example CVS and Aetna, as well as the evolving role of retailers such as Amazon in the healthcare space.

They reimagined businesses creating services that became essential to our lives — before we even realized we needed them. Now, they are setting their sights on healthcare. And they have only just begun. I believe they are going to turn healthcare IT on its head in the best possible way.

People want healthcare that is convenient for them, that lets them be proactive about their health and provides a more personalized experience the same way they experience it in other categories. Healthcare providers such as Forward and Parsley Health are offering easy access to private healthcare services in malls or shared office spaces. For an increasing number of people, possessing health and wellness quickly is becoming the ultimate signifier of fashion, luxury, and personal wealth.

And we are seeing this trend play out in the workplace as well. Health and wellness as a luxury status symbol is emblematic of a larger trend toward wellness intelligence. It is estimated that nearly half of all Americans suffer from at least one chronic disease.

We as an industry have done a tremendous job treating the symptoms of these illnesses. But there needs to be a shift in focus in our healthcare system from treating symptoms to preventive action. And to think that the preventive action could be as simple as getting more whole food and less processed food.

Additionally, our growing reliance on production animals and the provenance of our food and protein sources will be an increasingly important topic in the years to come. When viewed in totality, there exist linkages to total wellness in humans, derived from responsible interactions with animals.

Kelly MacDonald — Rising Star Director, Commercial Finance and Technical Accounting, Ironwood Pharmaceuticals I believe that a continued shift in focus toward prevention rather than treatment will also impact the overall industry significantly. This shift will continue to evolve over time and ultimately will lead to a more efficient and cost-effective healthcare infrastructure.

This innovation coupled with real world evidence, especially in the U. Textbook concepts will become scientific and commercial reality more rapidly. The concept of cure will be re-defined because of these therapies and as such, medicine will become increasingly personalized. The associated infrastructure for the delivery of medicine will also have to keep up with the innovations. In the coming decades, gene editing could revolutionize the treatment of different diseases such as neurological disorders or cancers.

Susan Farkas — Rising Star Commercial Business Director, AstraZeneca Pharmaceuticals Scientific innovation will continue to be critically important so that life-changing medicines can be brought to market and enable patients to receive their best possible outcome. In response to the advance of precision medicine, the FDA will move away from its traditional operating structure, creating multi-disciplinary teams grouped by their deep understanding of a disease.

The Oncology Center of Excellence is the first such grouping that was formed in Breaking down traditional silos, the Center of Excellence was designed to increase communications and collaboration within the regulatory agency and with external stakeholders, including patients, advocacy groups, and researchers.

Patients have benefited from this new oncology-specific center through the approval of innovative products, including two cell-based gene therapies and the first biomarker-defined, pan-tumor therapy. The FDA has plans to expand this center of excellence model to other diseases such as immunotherapy and neuroscience.

Tara Mautone — Rising Star Senior Director, Chief of Staff, President, Daiichi Sankyo Clinical and technological innovation, specifically around immunotherapy, gene therapy, and wearable digital devices will continue to be a trend. How these types of innovation shape the future of healthcare will largely depend on how prepared we are to respond to all of the unknowns that accompany such innovation, and how well we anticipate the consequences both politically and economically.

Innovation is essential to bringing value to patients, and being more purposeful and deliberate about innovation is vital to driving growth. Technology is changing the way we approach our research and development activities since medicines are among the most powerful tools we have for patients to treat, cure, and manage chronic and life-threatening diseases.

We must continue to advance innovative medicines. In recent years, developments such as biosimilars, gene therapy, and precision medicine have been effective at treating many of these diseases. Innovate or die — the healthcare industry has to be willing to take prudent risks that do not impact patient care.

We need to consider smarter, more efficient processes from discovery through to patient interaction. The companies that take big leaps will be the ones to survive these uncertain times. Jennifer Broxmeyer — Rising Star Director of Compliance and Associate General Counsel, athenahealth Interoperability has taken far longer than it should, but with pressure from Congress and a proposed framework from ONC, vendors are moving toward interoperability of medical records. If done correctly, it should lead to better care, reduce duplicate testing, and save lives.

The Internet has allowed access to more information for patients. It is critical for us in the industry to enable the provision of credible medical information for patients to avoid the misinformation that is available on so many sites. In addition, we must identify innovative ways to include and share the patient voice throughout the lifecycle of any new therapy for patients. Eventually, business will follow. We need to put ourselves into the shoes of patients and continue to listen to them, their families, and their caregivers and truly understand what their needs are.

Patients across generations continue to have access to more information through advancement of technology. Patients find themselves with more questions and options. Patients expect more value for the same or less cost. Healthcare providers will continue to navigate how to differentiate themselves as an outstanding provider of care while also balancing the continued challenges of rising costs.

The patient voice and early engagement will become paramount in designing and conducting trials that are more widely accessible, more tolerable, and less burdensome. More engaged patients will be looking for beyond-the-pill support to accompany them in actively managing and living with their disease. In response to this environment, more and more people will become active participants in their own healthcare. Industry will play a key role in enabling better self-care.

This will happen first by championing increased consumer access to OTC treatment options through both switch and innovation, and secondly, by providing access to better quality health information, easy to use diagnostic tools, and technology, which will allow consumers to better understand and track their health stats.

Overall, I expect we will see consumers become even more connected to their health and I hope more confident in their ability to impact it for the better.

While drugs and devices are often the solution, how they are delivered and what they are delivered in, in conjunction with alternative medicine, increased mental health, patient education and support, and now, connected health may enhance what traditional medicine can do.

Perhaps most importantly, these options enhance the experience of patients as they go through the medical system. How can we creatively focus on every aspect of the patient? Bringing it one step further into research, how can we generate evidence that helps us understand what is most effective for each patient?

Kellie Malloy — Luminary Executive VP, Syneos Health Patients expect more from healthcare providers, and that is creating monumental change for our industry. Technology has made our lives easier, including how we access and assess our personal healthcare. After my son was diagnosed with Type 1 diabetes a year ago, I experienced the many different spokes of healthcare from a very real, personal perspective. The process for understanding the impact of a new diagnosis and therapy regimen along with insurance coverage implications was mentally and emotionally exhausting.

I experienced the current landscape to be fragmented; I had to rely on sheer determination to pull together the necessary pieces of the puzzle when insurance originally declined our ER visit due to a miscoding and when I showed up to the pharmacy and got hit with an extraordinarily large subtotal.

While consumers today have more options and access to information than ever before, the journey is often still convoluted and difficult to navigate. A patient-centric approach, with increased communication, support, and training, must continue to be the primary focus and driver. Aligning upon what it means to successfully achieve patient empowerment and how to streamline the experience must continue to be the endpoint across the different stakeholders within the wide lens of healthcare.

Technology today allows them to understand and be involved in their own care, helping pharma and device companies have an even bigger impact on the patients they treat. Gone are the days of spun data and a good sales pitch. Customers exist in a surround-sound world and engage with brands across multiple channels, directly and indirectly.

The use of multichannel storytelling with a unified brand narrative that inspires action will be critical to meaningful customer engagement, conversion, and loyalty as we move into the next era of healthcare marketing. Courtney Cohen — Rising Star Associate Creative Director, Calcium USA One trend in healthcare will be that we will continue to see the development of therapies tailored to the individual genetic makeup, needs, and everyday lifestyle of the patient.

We will develop clinical care programs that are tailored to the specific patient. This will help to improve patient outcomes. The study of the microbiome of a person will shine the light on their metabolism and digestive process. The combination of the genetic and metabolic profile of an individual w be a profound combination for treatment of a disease.

I certainly did not imagine that a cure for cancer would be developed during my lifetime. To register for your screening go to my. For scheduling questions, contact the Participant Service Center at or wellness questdiagnostics. An Aetna Health Assessment is a brief questionnaire that will take approximately 15 minutes to complete.

Print your Mayo Clinic Health Assessment for proof of completion to confirm with your on-site Aetna wellness coordinator. Passport to Health — The Bexar County Passport to Health is a voluntary wellness program which allows Bexar County employees to earn an incentive by participating in a variety of health and wellness services and activities.

Quest Health Screening — Series of health tests that includes: Screenings can help provide insight about your health status and identify any potential health risks to help you make positive lifestyle changes. All results will remain confidential.

The questionnaire is easy to read and simple to complete. It also provides information to address your specific health needs, and a health summary that allows you to keep record and compare results over time.

When you complete the online healthassessment, you will receive a report detailing your specific health risks. Preventive Care — Focuses on evaluating your current health status and allows you to obtain early diagnosis and treatment to help avoid more serious health problems in the future. Through preventive exams and routine health screenings, your doctor can determine your current health status and detect early warning signs of more serious problems.

A Physician or licensed medical provider is on staff daily. Whenever possible, appointments are preferred and may be scheduled by calling The Clinic is open Monday through Friday from 7: The Clinic is closed on all County Holidays. Please don't hesitate to call the Clinic at Bexar County and Aetna are pleased to offer healthcare services for Bexar County employees through Univeristy Health System's network of health centers. Click here to ready the flyer and view locations!

Located at W. Clinic is available to everyone! The new tier is available to all employees provided that certain criteria are met, as outlined below:. Please note that the following individuals are not eligible for designation as a Plus One Qualifying Adult:.

Open enrollment occurs at the end of each year, and is the only time during the year that changes can be made, with the exception of a change in family status. You can enroll for coverage within 30 days of your eligibility date or during the Annual Enrollment period.

The benefit choices you make during your enrollment will remain in effect for the entire plan year January 1 - December You will have the opportunity to change your benefit selections once a year during the Annual Enrollment period or during the year if you experience a family status change within 30 days. If you experience a qualified change in family status, you will have the opportunity to make mid-year changes to your benefit elections.

Changes must be made within 30 days of the event date. My organization has a bowling arena. And everyone knows that bowling has many Health Benefits.

In addition to securing your […]. Top 10 Health Benefits of Drinking Coffee. Top 10 Healthy Birthday Activities. Top 10 Tips To Improve Posture. Top 10 Unhealthy Fashion Trends.